Establishment Labs (NASDAQ:ESTA) Share Price Breaks Above Fifty Day Moving Average – What’s Next?

Posted by Francis Steltz on Oct 29th, 2026

Establishment Labs Holdings Inc. (NASDAQ:ESTA – Get Free Report) shares passed above its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of $67.38 and traded as high as $70.53. Establishment Labs shares last traded at $68.97, with a volume of 790,787 shares traded.

Analyst Upgrades and Downgrades

Several equities analysts have commented on ESTA shares. Citigroup upgraded Establishment Labs from a “neutral” rating to a “buy” rating and set a $92.00 target price for the company in a research report on Thursday, August 13th. JPMorgan Chase & Co. lifted their price target on Establishment Labs from $84.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. TD Cowen reduced their price target on Establishment Labs from $117.00 to $95.00 and set a “buy” rating on the stock in a report on Monday. BTIG Research reaffirmed a “buy” rating and issued a $103.00 price objective on shares of Establishment Labs in a research note on Tuesday, September 1st. Finally, Needham & Company LLC upped their price objective on Establishment Labs from $86.00 to $95.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Nine equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $96.11.

Read Our Latest Report on Establishment Labs

Establishment Labs Stock Up 3.0%

The firm has a market capitalization of $2.06 billion, a price-to-earnings ratio of -52.65 and a beta of 1.06. The company has a debt-to-equity ratio of 12.11, a current ratio of 3.84 and a quick ratio of 2.52. The stock has a fifty day moving average of $67.38 and a two-hundred day moving average of $72.36.

Establishment Labs (NASDAQ:ESTA – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.34) by ($0.05). Establishment Labs had a negative return on equity of 196.69% and a negative net margin of 15.82%. The company had revenue of $67.54 million for the quarter, compared to analyst estimates of $65.79 million. During the same period in the previous year, the firm posted ($0.57) earnings per share. The firm’s quarterly revenue was up 31.7% compared to the same quarter last year. Sell-side analysts anticipate that Establishment Labs Holdings Inc. will post -1.08 earnings per share for the current year.

Institutional Trading of Establishment Labs

A number of large investors have recently bought and sold shares of ESTA. State of Wyoming raised its stake in Establishment Labs by 102.1% during the 3rd quarter. State of Wyoming now owns 2,057 shares of the company’s stock worth $132,000 after buying an additional 1,039 shares during the period. China Universal Asset Management Co. Ltd. boosted its holdings in Establishment Labs by 220.0% in the third quarter. China Universal Asset Management Co. Ltd. now owns 2,560 shares of the company’s stock worth $163,000 after acquiring an additional 1,760 shares in the last quarter. Sterling Capital Management LLC grew its stake in Establishment Labs by 849.5% in the third quarter. Sterling Capital Management LLC now owns 902 shares of the company’s stock valued at $58,000 after acquiring an additional 807 shares during the period. State of Alaska Department of Revenue acquired a new stake in Establishment Labs in the third quarter valued at approximately $80,000. Finally, Engineers Gate Manager LP grew its stake in Establishment Labs by 7.5% in the second quarter. Engineers Gate Manager LP now owns 31,458 shares of the company’s stock valued at $2,699,000 after acquiring an additional 2,191 shares during the period. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Establishment Labs Company Profile

(Get Free Report)

Establishment Labs Holdings Inc is a medical technology company focused on women’s health and the breast aesthetics market. The company develops, manufactures and commercializes breast implants and related technologies designed for breast augmentation, reconstruction and revision procedures.

Its product portfolio includes the Motiva line of breast implants, which incorporates the company’s proprietary implant materials, surface technologies and design features. Establishment Labs also offers Motiva Flora tissue expanders for use in breast reconstruction and has developed Mia Femtech, a minimally invasive breast enhancement procedure intended to provide a less invasive alternative to traditional augmentation techniques.

Founded in 2004, Establishment Labs is headquartered in Costa Rica and serves physicians, hospitals and patients in international markets.